Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

CEOs Sell Millions Worth of These 3 Big Name Stocks—What It Means for Investors

CEOs at Casey's, Rocket Lab and RH sold millions in shares recently, but context suggests the moves reflect diversification rather than clear bearish signals for investors.

Fission for Profits: Unlocking America’s Uranium Vault

Fission for Profits: Unlocking America’s Uranium Vault

Energy Fuels shares fell after its $1.9 billion Vacuumschmelze deal sparked dilution concerns, but CEO Ross Bhappu bought $967,920 in stock amid 19% short interest.

The SK Hynix IPO and 2027’s AI Memory Squeeze

The SK Hynix IPO and 2027’s AI Memory Squeeze

SK Hynix's US debut raised $28.1 billion before shares fell, while Micron also dropped in sympathy, as memory makers face a persistent HBM supply crunch amid a maturing triopoly.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts

Meta Platforms stock is rallying as its new Muse Spark 1.1 AI model shows improved intelligence scores and marks Meta's first push to monetize AI models via per-token pricing.

Why Welltower's Growth Story Might Outrun Its Rich Valuation

Welltower's NOI and NFFO growth support its premium valuation, but housing data on senior aging-in-place trends and mortgage rate lock-in complicate its demographic growth thesis.

One Short- and One Long-Term ETF for Quantum Computing Bulls

As quantum stocks slump in 2025, ETFs like WisdomTree's WQTM and Defiance's QTUM offer diversified exposure, suiting long-term and short-term investors with differing risk and liquidity needs.

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions

Wainua missed its Phase 3 endpoint, hitting Ionis Pharmaceuticals hard while AstraZeneca absorbed the blow easily, boosting rivals BridgeBio, Pfizer and Alnylam Pharmaceuticals.

inkl

Read news from The Economist, FT, and more,
with one subscription

Why Micron Is Doubling Down While the HBM Shortage Persists

Why Micron Is Doubling Down While the HBM Shortage Persists

Micron plans $250 billion in U.S. investment amid a persistent HBM shortage, as analysts maintain a Buy consensus and see substantial upside in the stock's valuation.

Analysts See Major Upside for These 5 Stocks

Analysts See Major Upside for These 5 Stocks

NVIDIA, Vistra, Mastercard, Micron, and Energy Transfer carry Buy ratings, high MarketRank scores, and double-digit analyst-implied upside ahead of earnings season.

China's Helium Ban Could Reshape the AI Supply Chain

China's Helium Ban Could Reshape the AI Supply Chain

China, Russia, and Qatar export curbs have triggered a global helium shortage critical to chip fabrication, pushing prices higher and boosting suppliers like Linde PLC.

AMD's 5C Deal Positions It as a Direct NVIDIA Rival

AMD's 5C Deal Positions It as a Direct NVIDIA Rival

AMD's 5C data center partnership positions it as a full-stack AI competitor to NVIDIA, with analysts citing strong price targets, growing coverage, and hypergrowth revenue forecasts ahead.

AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit

AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit

AST SpaceMobile shares remain volatile amid partnership gains and BlueBird satellite launches, offset by mounting losses, cash burn, and repeated EPS misses that keep Wall Street cautious.

3 Dividend Stocks with Growth on Tap for the Second Half

3 Dividend Stocks with Growth on Tap for the Second Half

Amid market volatility and geopolitical uncertainty, IBM, Kinder Morgan and Templeton Emerging Markets Fund offer dividend growth and attractive total return potential for investors seeking safety.

3 Overlooked Stocks Positioned for the Next Market Rotation

3 Overlooked Stocks Positioned for the Next Market Rotation

Oxford Club strategist Marc Lichtenfeld highlights diversification beyond tech, spotlighting Ligand Pharmaceuticals, Aflac and Atlantic Union Bankshares as healthcare, insurance and banking stocks gaining quiet momentum.

Get all your
news in one place.

100's of premium titles.
One news app.

3 Non-Tech Stocks Still Winning Big on AI

Powell Industries, AAON, and EMCOR Group are benefiting from surging data center demand for power, HVAC, and construction services, offering AI-linked growth outside the tech sector.

Achieve Robust Diversification With These 3 Equal-Weight ETFs

Equal-weight ETFs like RSP, QQEW, and DFVE offer alternatives to market-cap-weighted funds, providing more balanced exposure across holdings with 2026 YTD returns near 12-13%.

3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk

Federal support for MP Materials, USA Rare Earth, and others is rebuilding U.S. rare-earth refining. REMX, EART, and SETM ETFs offer diversified ways to invest in this supply chain.

Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs

Microsoft is routing some Copilot prompts to its in-house MAI models to cut reliance on OpenAI and Anthropic, aiming to boost margins as MSFT shares trade off 2026 lows.

Get all your
news in one place.

100's of premium titles.
One news app.

Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing

Delta Air Lines posted strong Q2 2026 results and raised guidance, driven by demand and premiumization, with analysts holding a Moderate Buy rating and price targets up to $110-$116.

This Dividend ETF Choice Could Shape Your Income Strategy Through 2026

VYM and SCHD both offer low-cost dividend exposure, but differ in methodology, yield, and holdings—VYM emphasizes broad, higher-yield diversification, while SCHD focuses on stricter, dividend-growth criteria.

Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks

Michael Burry bought DraftKings and Flutter shares, betting regulation will curb prediction markets like Kalshi, as Wall Street analysts also see both sportsbook stocks as undervalued.

Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs

Starbucks (SBUX) is building internal AI tools to replace Microsoft and IBM software, targeting $400 million in annual vendor spend and cutting $30 million from its tech budget.

Power Struggle: Wolfspeed Sues Navitas Over AI Chips

Wolfspeed sued Navitas Semiconductor over five wide-bandgap patents, seeking an import injunction and damages, as both companies face debt, cash burn and shifting AI datacenter supply chains.

Why WD-40 Is Proving Great Businesses Never Go Out of Style

WD-40's fiscal Q3 revenue rose 24% and guidance increased, sending shares to a multi-year high. Analysts hold a Buy consensus with a $305 price target, and a new $100 million buyback was authorized.

Pushing the Edge: Super Micro Computer Reboots the AI Landscape

Super Micro Computer launched a Kubernetes edge AI appliance with Red Hat and Portworx targeting sovereign AI demand, even as shares fell 30% and short interest rose to about 19% of its float.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Emerging Markets

Places

398,190 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play